Optic pathway gliomas in children: prognostic factors, response assessment, role of carboplatin and vincristine chemotherapy regime-Reference-Cited by-同舟云学术

Optic pathway gliomas in children: prognostic factors, response assessment, role of carboplatin and vincristine chemotherapy regime

Published:2019-04-21 Issue:1 Volume:18 Page:62-72
ISSN:2414-9314
Container-title:Pediatric Hematology/Oncology and Immunopathology
language:
Short-container-title:Voprosy gematologii/onkologii i immunopatologii v pediatrii

Author:

Valiakhmetova E. F.¹^ORCID,Budanov O. I.²^ORCID,Gorelyshev S. K.³,Serova N. K.¹,Lasareva L. A.¹,Shiskina L. V.¹,Mazerkina N. A.¹,Trunin Y. Y.¹,Chulkova S. V.⁴^ORCID,Grishchenko N. V.⁴,Egorova A. V.⁴^ORCID,Papusha L. I.²^ORCID,Novichkova G. А.⁵^ORCID,Karachunskii A. I.⁵^ORCID

Affiliation:

1. N.N. Burdenko National Medical Research Center of neurosurgery Ministry of Healthcare of Russian Federation

2. Dmitriy Rogachev National Medical Research Center of Pediatric Hematology, Oncology, Immunology Ministry of Healthcare of Russian Federation

3. N.N. Burdenko National Medical Research Center of neurosurgery Ministry of Healthcare of Russian Federation; N.I. Pirogov Russian National Research Medical University

4. N.I. Pirogov Russian National Research Medical University; N.N. Blokhin National Medical Research Center of oncology Ministry of Healthcare of Russian Federation

5. N.I. Pirogov Russian National Research Medical University; Dmitriy Rogachev National Medical Research Center of Pediatric Hematology, Oncology, Immunology Ministry of Healthcare of Russian Federation

Publisher

Fund Doctors, Innovations, Science for Children

Subject

Oncology,Hematology,Immunology,Immunology and Allergy,Pediatrics, Perinatology and Child Health

Reference30 articles.

1. Jahraus C.D., Tarbell N.J. Optic pathway gliomas. Pediatric Blood and Cancer 2006. 5 (46): 586-96.

2. Nicolin G., Parkin P., Mabbott D., Hargrave D., Bartels U., Tabori U., et al. Natural history and outcome of optic pathway gliomas in children. Pediatric Blood and Cancer 2009; 7 (53): 1231-7.

3. Gnekow A.K, Falkenstein F., von Hor-stein S. Long-term follow-up of the multicenter, multidisciplinary treatment study HIT-LGG-96 for low-grade glioma in children and adolescents of the German Speaking Society of Pediatric Oncology and Hematology. Neuro Oncology 2012; 14: 1265-84.

4. Tsang D.S., Murphy E.S., Merchant T.E. Radiation Therapy for Optic Pathway and Hypothalamic Low-Grade Gliomas in Children. International Journal of Radiation Oncology Biology Physics 2017; 3 (99): 642-51.

5. Merchant T.E., Conklin H.M., Wu S., Lus-tig R.H., Xiong X. Late effects of conformal radiation therapy for pediatric patients with low-grade glioma: Prospective evaluation of cognitive, endocrine, and hearing deficits. Journal of Clinical Oncology 2009; 22 (27): 3691-7.

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Glioma of the anterior visual pathway in children. Part II. Current treatment trends;Russian Pediatric Ophthalmology;2024-06-14

2. PEDIATRIC OPTIC PATHWAY GLIOMA: DIENCEPHALIC SYNDROME;Siberian journal of oncology;2021-03-06

3. Low-grade gliomas with the V600E mutation in the BRAF gene in children: clinical features and treatment options;Pediatric Hematology/Oncology and Immunopathology;2020-12-22

4. Optic pathway gliomas associated with neurofibromatosis type I in children;Pediatric Hematology/Oncology and Immunopathology;2019-12-31

5. Optic pathway gliomas associated with neurofibromatosis type I in children;Pediatric Hematology/Oncology and Immunopathology;2019-12-31